Pharmacy interventions on prescribing in nursing homes: From evidence to practice

Therapeutic Advances in Drug Safety

Volumn 2, Issue 3, 2011, Pages 103-112

  Hughes, Carmel M ^a   Lapane, Kate L ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

interventions; nursing homes; pharmacist; prescribing

Indexed keywords

EID: 84993683484     PISSN: 20420986     EISSN: 20420994     Source Type: Journal    
DOI: 10.1177/2042098611406167     Document Type: Review

References (53)

1. Alldred D.P. Zermansky A.G. Petty D.R. Raynor D.K. Freemantle N. Eastaugh J. (2007) Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions. Int J Pharm Pract 15: 93–99.
2. Aronson J.K. (2004) In defence of polypharmacy. Br J Clin Pharmacol 57: 119–120.
3. Avorn J. (2010) Medication use in older patients: better policy could encourage better practice. JAMA 340: 1606–1607.
4. Banerjee S. (2009) The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services, London: Department of Health.
5. Barber N.D. Alldred D.P. Raynor D.K. Dickinson R. Garfield S. Jesson B. (2009) Care homes’ use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care 18: 341–346.
6. Bernabei R. Gambassi G. Lapane K. Landi F. Gatsonis C. Dunlop R. (1998) Management of pain in elderly patients with cancer. JAMA 279: 1877–1882.
7. Bernsten C. Bjorkman I. Caramona M. Crealey G. Frokjaer B. Grundberger E. (2001) Improving the well-being of elderly patients via community pharmacy based provision of pharmaceutical care. Drugs Aging 18: 63–77.
8. Boockvar K. Fishman E. Kyriacou C.K. Monias A. Gavi S. Cortes T. (2004) Adverse events due to discontinuations in patients transferred between acute and long-term care facilities. Arch Intern Med 164: 545–550.
9. Crotty M. Halbert J. Rowett D. Giles L. Birks R. Williams H. (2004a) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33: 612–612.
10. Crotty M. Rowett D. Spurling L. Giles L.C. Phillips P.A. (2004b) Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharm 2: 257–264.
11. Crotty M. Whitehead C. Rowett D. Halbert J. Weller D. Finucane P. (2004c) An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial. BMC Health Services Res 4: 6–6.
12. Dwyer L.L. Han B. Woodwell D.A. Rechtsteiner E.A. (2010) Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharm 8: 63–72.
13. Eichmann M.A. Griffin B.P. Lyons J.S. Larson D.B. Finkel S. (1992) An estimation of the impact of OBRA-87 on nursing home care in the United States. Hosp Community Psychiatry 43: 781–789.
14. Elon R. Pawlson L.G. (1992) The impact of OBRA on medical practices within nursing facilities. J Am Geriatr Soc 40: 958–963.
15. Fahey T. Montgomery A.A. Barnes J. Protheroe J. (2003) Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 326: 580–584.
16. Franic D.M. Jiang J.Z. (2006) Potentially inappropriate drug use and health-related quality of life in the elderly. Pharmacotherapy 26: 768–778.
17. Furniss L. Burns A. Craig S.K.L. Scobie S. Cooke J. Faragher B. (2000) Effects of a pharmacist–s medication review in nursing homes: randomised controlled trial. Br J Psychiat 176: 563–567.
18. Garrard J. Chen V. Dowd B. (1995) The impact of the 1987 Federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Pub Health 85: 771–776.
19. Gurwitz J. (2004) Polypharmacy. A new paradigm for quality drug therapy in the elderly?. Arch Intern Med 164: 1957–1959.
20. Gurwitz J.H. Field T.S. Judge J. Rochon P. Harrold L.R. Cadoret C. (2005) The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 118: 251–258.
21. Health Care Financing Administration. (1995) State Operations Manual, Baltimore, MD: HCFA.
22. Hughes C.M. Goldie R. (2009) “I just take what I am given”: adherence and resident involvement in decision making on medicines in nursing homes for older people: a qualitative survey. Drugs Aging 26: 505–517.
23. Hughes C.M. Lapane K.L. (2005) Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?. Drugs Aging 22: 339–351.
24. Hughes C.M. Lapane K.L. Mor V. (1999) Impact of legislation on nursing home care in the United States: lessons for the United Kingdom. BMJ 319: 1060–1062.
25. Hughes C.M. Lapane K.L. Mor V. Ikegami N. Jonsson P.V. Ljunggren G. (2000) The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 48: 931–937.
26. Hughes C.M. Lapane K. Watson M.C. Davies H.T.O. (2007) Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging 24: 81–93.
27. Hughes C.M. Wright R.M. Lapane K.L. (2006) Use of medication technicians in US nursing homes: part of the problem or part of the solution?. J Am Med Dir Assoc 7: 294–304.
28. Ingman S.R. Lawson I.R. Pierpaoli P.G. Blake P. (1975) A survey of the prescribing and administration of drugs in a long-term care institution for the elderly. J Am Geriatr Soc 23: 309–316.
29. Institute of Medicine. (1986) Improving the Quality of Care in Nursing Homes, Washington, DC: National Academy Press.
30. Kalchthaler T. Coccaro E. Lichtiger S. (1977) Incidence of polypharmacy in a long-term care facility. J Am Geriatr Soc 25: 308–313.
31. Kirkevold O. Engedal K. (2005) Concealment of drugs in food and beverages in nursing homes: cross sectional study. BMJ 330: 2023–2023.
32. Lapane K.L. Hughes C.M. Christian J.B. Daiello L.A. Cameron K. Feinberg J.L. (2011b) Evaluation of the Fleetwood model of long term care pharmacy. J Am Med Dir Assoc, in press.
33. Lapane K.L. Hughes C.M. Daiello L. Cameron K. Feinberg J.L. (2011c) Impact of pharmacist-led multi-component intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. J Am Geriatr Soc, accepted for publication.
34. Lapane K.L. Quilliam B.J. Chow W. Kim M. (2011a) The association between persistent pain and quality of life measures among nursing home residents. J Am Med Dir Assoc, in press.
35. Levenson S.A. Saffel D. (2007) The consultant pharmacist and the physician in the nursing home: roles, relationships and a recipe for success. Consult Pharm 33: 71–82.
36. Morgan K. Gilleard C.J. Reive A. (1982) Hypnotic usage in residential homes for the elderly: a prevalence and longitudinal analysis. Age Ageing 11: 229–234.
37. Murray L.M. Laditka S.B. (2010) Care transitions by older adults from nursing homes to hospitals: implications for long-term care practice, geriatric education and research. J Am Med Dir Assoc 11: 231–238.
38. Office of the Inspector General. (1997) Prescription drug use in nursing homes. In: Report 2: an inside view by consultant pharmacists (Report number OEI-06-96-00081), Washington, DC: US Department of Health and Human Services (DHHS).
39. Pacini M. Smith R.D. Wilson E.C.F. Holland R. (2007) Home-based medication review in older people. Is it cost-effective?. Pharmacoeconomics 35: 171–180.
40. Patterson S.M. Hughes C.M. Cardwell C. Lapane K.L. Murray A.M. Crealey G.E. (2011) An evaluation of an adapted United States model of pharmaceutical care for nursing home residents in Northern Ireland (Fleetwood NI Study): a cost-effectiveness analysis. J Am Geriatr Soc, in press.
41. Patterson S.M. Hughes C.M. Crealey G. Cardwell C. Lapane K. (2010) An evaluation of an adapted United States model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood NI Study). J Am Geriatr Soc 58: 44–53.
42. Patterson S.M. Hughes C.M. Lapane K.L. (2007) Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom. Pharm World Sci 29: 517–525.
43. Roberts M.S. Stokes J.A. King M.A. Lynne T.A. Purdie D.M. Glasziou P.P. (2001) Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmac 51: 257–265.
44. Rovner B.W. Edelman B.A. Cox M.P. Schmuely Y. (1992) The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 149: 1390–1392.
45. Schmidt I. Claesson C.B. Westerholm B. Nilsson L.G. (1998a) Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 32: 27–32.
46. Schmidt I. Claesson C.B. Westerholm B. Nilsson L.G. Svarstad B.L. (1998b) The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 46: 77–82.
47. Stewart R. May F.E. Moore M.T. Hale W.E. (1989) Changing patterns of psychotropic drug use in the elderly: a five-year update. Drug Intell Clin Pharm 23: 610–613.
48. Stoudemire A. Smith D.A. (1996) OBRA regulations and the use of psychotropic drugs in long-term care facilities. Impact and implications for geropsychiatric care. Gen Hosp Psych 18: 77–94.
49. Tessier E.G. (1993) Evaluating drug therapy: principles and practices for long-term care providers. In: Tessier E.G. Gaziano G. (eds) Geriatric Drug Handbook for Long-term Care, Baltimore, MD: Williams and Wilkins, 165–174.
50. Thomson M.S. Gruneir A. Lee M. Baril J. Field T.S. Gurwitz J.H. Rochon P.A. (2009) Nursing time devoted to medication administration in long-term care: clinical, safety, and resource implications. J Am Geriatr Soc 57: 266–272.
51. Walley T. Scott A.K. (1995) Prescribing in the elderly. Postgrad Med J 72: 466–471.
52. Won A.B. Lapane K.L. Vallow S. Schein J. Morris J.N. Lipsitz L.A. (2004) Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc 52: 867–874.
53. Zermansky A.G. Alldred D.P. Petty D.R. Raynor D.K. Freemantle N. Eastaugh J. (2006) Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 35: 585–591.